A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis

Not Applicable

Completed

• Conditions: Idiopathic pulmonary fibrosis; Respiratory; Other interstitial pulmonary diseases with fibrosis

• Registration Number: ISRCTN13784514
• Lead Sponsor: Hull and East Yorkshire Hospitals NHS Trust

Brief Summary

2019 protocol in https://pubmed.ncbi.nlm.nih.gov/31649946/ (added 01/06/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-05
• Study Completion: 2020-05-31
• Last Update Posted: 14 June 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Males and females aged =50 years. This age cut-off is chosen because IPF is very rare under 50 years of age making an alternative diagnosis likely
2. IPF diagnosed by multidisciplinary team (MDT) consensus in accordance with international guidelines
3. mMRC dyspnoea grades 3 or 4 despite optimal management
4. Oxygen saturation =90% on air/using usual oxygen prescription
5. Able to give informed consent

Exclusion Criteria

1. Significant comorbid cardiorespiratory disease other than IPF considered by the principal investigator to be the primary cause of breathlessness
2. Pulmonary rehabilitation: completed < = 3 months previously
3. Breathlessness clinic attendance: completed < = 3 months previously
4. Unwilling or unable to consent or complete study measures

Study & Design

• Study Type: Interventional
• Study Design: Not specified